Phase
Condition
Oppositional Defiant Disorder (Odd)
Pseudobulbar Affect
Treatment
N/AClinical Study ID
Ages 8-12 All Genders
Study Summary
Eligibility Criteria
Inclusion
Inclusion:
Age 8-12
Insurance provided by Magellan Healthcare OR participant is covered by insurance in Massachusetts and has access to Explanation of Benefits information via online portal
Has made a behavioral health claim in the past year
MOAS score of greater than or equal to 2
Evidence of ADHD, ODD, CD, DMDD, IED, or ASD by MINI-KID
Parent or guardian is fluent in English
WiFi at home (for Mightier tablet connection)
Access to a computer or tablet in the home
Exclusion:
IQ < 70 (by medical record or clinician judgment)
Extremely limited verbal capacity
Change in medication or medication dosage in the past month or planned change in medication or medication dosage in the next month
Active suicidal ideation
History of suicide attempt and current depression
Physical limitations that preclude the use of Mightier
Sensory sensitivities that would preclude wearing an arm (or leg) heart rate monitor
Evidence of psychosis, mania, alcohol use disorder, substance use disorder, or PTSD by MINI-Kid
Ongoing or within the month prior to baseline visit placement in foster care or residential facility
Study Design
Connect with a study center
Neuromotion Inc
Boston, Massachusetts 02110
United StatesSite Not Available
Not the study for you?
Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.